Cerebral amyloid angiopathy: clinical presentations and management challenges in the Australian context

Area of Science:

• Neurology
• Pathology
• Geriatrics

Background:

• Cerebral amyloid angiopathy (CAA) is a cerebrovascular disease characterized by amyloid-beta deposition in brain arteries.
• It is a significant risk factor for intracerebral and subarachnoid hemorrhage, particularly in older adults.
• CAA frequently co-exists with other neurodegenerative proteinopathies, complicating clinical presentation and management.

Purpose of the Study:

• To review the existing literature on cerebral amyloid angiopathy (CAA).
• To summarize key findings regarding CAA's clinical manifestations and pathology.
• To explore clinical challenges in diagnosing and managing CAA, including hemorrhage and co-existing conditions.

Main Methods:

• Systematic review of existing literature on cerebral amyloid angiopathy.
• Analysis of clinical manifestations, pathology, and epidemiological data.
• Focus on diagnostic strategies and management of intracranial hemorrhage and comorbidities.

Main Results:

• CAA is characterized by amyloid-beta deposition in cerebral vasculature, increasing hemorrhage risk.
• Incidence rises with age; often asymptomatic but linked to severe bleeding events.
• Co-existence with other proteinopathies is common, posing diagnostic and therapeutic hurdles.

Conclusions:

• Cerebral amyloid angiopathy is an increasingly relevant condition for adult physicians due to its prevalence and association with hemorrhage.
• Effective diagnosis and management of CAA, especially concerning intracranial hemorrhage and concurrent diseases, remain critical clinical challenges.
• Further research is needed to refine diagnostic tools and therapeutic strategies for this complex cerebrovascular disorder.